Penella J. Woll

University of Sheffield — United Kingdom

Medicine · Health Sciences

53h-index13.1kcitations269works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Research Studies(67), Lung Cancer Treatments and Mutations(56), Sarcoma Diagnosis and Treatment(31), Vascular Tumors and Angiosarcomas(23), RNA modifications and cancer(22)

Publications266 total

Germline HLA heterozygosity is associated with decreased lung cancer risk
Human Genetics and Genomics Advances·2026Open Access
Genes associated with genetic and rare lung diseases and the risk of lung cancer
2025Open Access
Selumetinib in Combination with Anti Retroviral Therapy in HIV-associated Kaposi sarcoma (SCART): an open-label, multicentre, phase I/II trial
BMC Cancer·2025Open Access
Identification of genetically predicted DNA methylation markers associated with non–small cell lung cancer risk among 34,964 cases and 448,579 controls
Cancer·2023· 7 citedOpen Access
Axitinib in patients with advanced/metastatic soft tissue sarcoma (Axi-STS): an open-label, multicentre, phase II trial in four histological strata
British Journal of Cancer·2023· 10 citedOpen Access
Candidate pathway analysis of surfactant proteins identifies<i>CTSH</i>and<i>SFTA2</i>that influences lung cancer risk
Human Molecular Genetics·2023· 10 citedOpen Access
Supplementary Data from Ganetespib in Combination with Pemetrexed–Platinum Chemotherapy in Patients with Pleural Mesothelioma (MESO-02): A Phase Ib Trial
2023Open Access
Data from Ganetespib in Combination with Pemetrexed–Platinum Chemotherapy in Patients with Pleural Mesothelioma (MESO-02): A Phase Ib Trial
2023Open Access
MESO-02 Trial Protocol from Ganetespib in Combination with Pemetrexed–Platinum Chemotherapy in Patients with Pleural Mesothelioma (MESO-02): A Phase Ib Trial
2023Open Access
Data from Ganetespib in Combination with Pemetrexed–Platinum Chemotherapy in Patients with Pleural Mesothelioma (MESO-02): A Phase Ib Trial
2023Open Access
MESO-02 Trial Protocol from Ganetespib in Combination with Pemetrexed–Platinum Chemotherapy in Patients with Pleural Mesothelioma (MESO-02): A Phase Ib Trial
2023Open Access
Supplementary Data from Ganetespib in Combination with Pemetrexed–Platinum Chemotherapy in Patients with Pleural Mesothelioma (MESO-02): A Phase Ib Trial
2023Open Access
Olaparib as maintenance treatment in patients with chemosensitive small cell lung cancer (STOMP): A randomised, double-blind, placebo-controlled phase II trial
Lung Cancer·2022· 40 citedOpen Access
Gene–gene interaction of AhRwith and within the Wntcascade affects susceptibility to lung cancer
European journal of medical research·2022· 2 citedOpen Access
Iam hiQ—a novel pair of accuracy indices for imputed genotypes
BMC Bioinformatics·2022· 3 citedOpen Access
Olaparib as Maintenance Treatment in Patients with Chemosensitive Small Cell Lung Cancer (STOMP): A Randomised, Double-Blind, Placebo-Controlled Phase II Trial
SSRN Electronic Journal·2022· 3 citedOpen Access
Gene-gene Interaction of AhR with and within the Wnt Cascade Affects Susceptibility to Lung Cancer
Research Square (Research Square)·2021Open Access
Gene-gene Interaction of AhR With and Within the Wnt Cascade Affects Susceptibility to Lung Cancer
Research Square (Research Square)·2021Open Access
I’am hiQ – A Novel Accuracy Index for Imputed Genotypes
Research Square (Research Square)·2021Open Access
Oncolytic herpesvirus therapy for mesothelioma – A phase I/IIa trial of intrapleural administration of HSV1716
Lung Cancer·2020· 53 cited
page 1 of 14Next →

Frequent Co-authors

Rayjean J. Hung(9), M. Dawn Teare(9), Philip Lazarus(9), Geoffrey Liu(8), Lambertus A. Kiemeney(8), Angeline S. Andrew(8), David C. Christiani(7), Loı̈c Le Marchand(7), Heike Bickeböller(7), Gad Rennert(7), John K. Field(7), Erik H.F.M. van der Heijden(7), Neil E. Caporaso(6), Adonina Tardón(6), Yun‐Chul Hong(6), Angela Risch(6), Eric J. Duell(6), James McKay(5), Mattias Johansson(5), Stig E. Bojesen(5)